On 28 de out. de 2025, NEO reported earnings of 0.03 USD per share (EPS) for Q3 25, beating the estimate of 0.02 USD, resulting in a 40.85% surprise. Revenue reached 187.80 milhão, compared to an expected 185.61 milhão, with a 1.18% difference. The market reacted with a -2.36% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 15 analistas forecast an EPS of 0.03 USD, with revenue projected to reach 190.14 milhão USD, implying an aumentar of 0.00% EPS, and aumentar of 1.25% in Revenue from the last quarter.
FAQ
What were NeoGenomics, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, NeoGenomics, Inc. reported EPS of $0.03, beating estimates by 40.85%, and revenue of $187.80M, 1.18% above expectations.
How did the market react to NeoGenomics, Inc.'s Q3 2025 earnings?
The stock price moved down -2.36%, changed from $10.16 before the earnings release to $9.92 the day after.
When is NeoGenomics, Inc. expected to report next?
The next earning report is scheduled for 16 de fev. de 2026.
What are the forecasts for NeoGenomics, Inc.'s next earnings report?
Based on 15
analistas, NeoGenomics, Inc. is expected to report EPS of $0.03 and revenue of $190.14M for Q4 2025.